European Journal of Internal Medicine
Volume 19, Issue 2 , Pages 129-134 , March 2008

Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room

  • George Habib

      Affiliations

    • Department of Medicine, Carmel Medical Center, Faculty of Medicine, Technion, Isreal Institute of Technology, Haifa, Israel
    • Corresponding Author InformationCorresponding author. Department of Medicine, Carmel Medical Center, Haifa 34362, Israel.
    • ,
  • Munir Nashashibi

      Affiliations

    • Department of Pathology, Carmel Medical Center, Haifa, Israel
    • ,
  • Arin Khateeb

      Affiliations

    • Pharmacy unit, Carmel Medical Center, Haifa, Israel
    • ,
  • Sharon Goichman

      Affiliations

    • Nutrition unit, Carmel Medical Center, Haifa, Israel
    • ,
  • Asia Kogan

      Affiliations

    • Emergency Room, Carmel Medical Center, Haifa, Israel

Received 22 January 2007 ,Revised 17 August 2007 ,Accepted 30 August 2007.

References 

  1. Nutescu EA, Shapiro NL, Chevalier A, Amin AN. Pharmacologic overview of current and emerging anticoagulants. Clevel Clin J Med. 2005;72(Suppl. 1):S2–S6
  2. Herman D, Locatelli I, Grabnar I, Peternel P, Stegnar M, Lainsak M, et al. The influence of co-treatment of carbamazebine, amiodarone and statins on warfarin metabolism and maintenance dose. Eur J Clin Pharmacol. 2006;62:291–296
  3. Froom P, Hermoni D, Barak M. Oral anticoagulation treatment-control, risks, benefits and informed consents. Harefuah. 2003;142:56–60
  4. Fasco MJ, Piper LJ, Kaminsky LS. Binding of R and S warfarin to hepatic microsomal cytochrome P-450. Arch Biochem Biophys. 1977;182:379–389
  5. Wells PS, Holbrook AN, Crowther NR, Hirsh J. interaction of warfarin with drugs and food. Ann Rheum Dis. 1994;121:676–683
  6. Rubinstein E. Comparative safety of the different macrolides. Int J Antimicrob Agents. 2001;18(Suppl 1):S71–S76
  7. Chen Y, Fergusson SS, Negishi M, Goldstein JA. Induction of human CYP2CP by rifampicin, hyperforin and Phenobarbital is mediated by the pregnane X receptor. J Pharmacol Exp Ther. 2004;308:495–501
  8. Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation. Thromb Haemost. 2002;87:199–205
  9. Antoniades C, Tousoulis D, Tentolouris C, Toutouza M, Marinou K, Goumas G, et al. Effects of antioxidants vitamin C and E on endothelial function and thrombosis/fibrinolysis system in smokers. Thromb Haemost. 2003;89:990–995
  10. Ifacts: Drug Interaction Facts. Facts and Comparisons; 2006;Version 9.0.1/2006.1.14
  11. Bolton-Smith C, Price RJ, Fenton ST, Harrington DJ, Shearer MJ. Compilation of a provisional UK database for the phylloquinone (vitamin K1) content of food. Br J Nutr. 2000;83(4):389–399
  12. Suttie JW. Vitamin K and human nutrition. J Am Diet Assoc. 1992;92:585–590
  13. Schurgers LJ, Shearer MJ, Hamulyak K, Stocklin E, Vermeer C. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose–response relationships in healthy subjects. Blood. 2004;104:2682–2689
  14. Kurnik D, Loebstein R, Rabinivitz H, Austerweil N, Halkin H, Almog S. Over the counter vitamin K-1 containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K-1 depleted patients. Thromb Haemost. 2004;92:1018–1024
  15. Froom P, Miron E, Barak M. Oral anticoagulants in the elderly. Br J Haematol. 2003;120:526–528
  16. Heimark LD, Wienkers L, Kunze K, Gibaldi M, Eddy AC, Trager WF, et al. The mechanism of the interaction between amiodarone and warfarin in humans. Clin Pharmacol Ther. 1992;51:398–407
  17. Kerin NZ, Blevins RD, Goldman L, Faitel K, Rubenfire M. The incidence, magnitude and time course of the amiodarone–warfarin interaction. Arch Int Med. 1988;148:1779–1781
  18. Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: Prospective evidence from observational and randomized protocols. Am J Med. 2004;116:651–656

PII: S0953-6205(07)00261-0

doi: 10.1016/j.ejim.2007.08.006

European Journal of Internal Medicine
Volume 19, Issue 2 , Pages 129-134 , March 2008

Article Tools